Literature DB >> 27094357

Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.

Fanfei Meng1, Sajid Asghar2, Yurui Xu1, Jianping Wang1, Xin Jin1, Zhilin Wang1, Jing Wang3, Qineng Ping1, Jianping Zhou4, Yanyu Xiao5.   

Abstract

Many nanoparticle matrixes have been demonstrated to be efficient in brain targeting, but there are still certain limitations for them. To overcome the shortcomings of the existing nanoparticulate systems for brain-targeted delivery, a lipoprotein resembling protein-free nanostructured lipid carrier (PS80-NLC) loaded with curcumin was constructed and assessed for in vitro and in vivo performance. Firstly, single factor at a time approach was employed to investigate the effects of various formulation factors. Mean particle sizes of ≤100nm, high entrapment efficiency (EE, about 95%) and drug loading (DL, >3%) were obtained for the optimized formulations. In vitro release studies in the presence of plasma indicated stability of the formulation under physiological condition. Compared with NLC, PS80-NLC showed noticeably higher affinity for bEnd.3 cells (1.56 folds greater than NLC) but with lower uptake in macrophages. The brain coronal sections showed strong and widely distributed fluorescence intensity of PS80-NLC than that of NLC in the cortex. Ex vivo imaging studies further confirmed that PS80-NLC could effectively permeate BBB and preferentially accumulate in the brain (2.38 times greater than NLC). The considerable in vitro and in vivo performance of the safe and biocompatible PS80-NLC makes it a suitable option for further investigations in brain targeted drug delivery.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain targeting; Curcumin; Drug delivery; Lipoprotein; Protein-free nanostructured lipid carrier

Mesh:

Substances:

Year:  2016        PMID: 27094357     DOI: 10.1016/j.ijpharm.2016.04.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Application of computational tools for the designing of Oleuropein loaded nanostructured lipid carrier for brain targeting through nasal route.

Authors:  Sucharitha Palagati; Satyanarayana Sv; Bhaskar Reddy Kesavan
Journal:  Daru       Date:  2019-11-25       Impact factor: 3.117

2.  Dual Nanostructured Lipid Carriers/Hydrogel System for Delivery of Curcumin for Topical Skin Applications.

Authors:  Rosa Calderon-Jacinto; Pietro Matricardi; Virginie Gueguen; Graciela Pavon-Djavid; Emmanuel Pauthe; Violeta Rodriguez-Ruiz
Journal:  Biomolecules       Date:  2022-06-03

Review 3.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Authors:  Christos Tapeinos; Matteo Battaglini; Gianni Ciofani
Journal:  J Control Release       Date:  2017-08-26       Impact factor: 9.776

4.  Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.

Authors:  Cihui Tian; Sajid Asghar; Yifan Wu; Zhipeng Chen; Xin Jin; Lining Yin; Lin Huang; Qineng Ping; Yanyu Xiao
Journal:  Int J Nanomedicine       Date:  2017-10-27

Review 5.  Formulations of Curcumin Nanoparticles for Brain Diseases.

Authors:  María L Del Prado-Audelo; Isaac H Caballero-Florán; Jorge A Meza-Toledo; Néstor Mendoza-Muñoz; Maykel González-Torres; Benjamín Florán; Hernán Cortés; Gerardo Leyva-Gómez
Journal:  Biomolecules       Date:  2019-02-08

Review 6.  Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.

Authors:  Lu Yan; Min-Song Guo; Yue Zhang; Lu Yu; Jian-Ming Wu; Yong Tang; Wei Ai; Feng-Dan Zhu; Betty Yuen-Kwan Law; Qi Chen; Chong-Lin Yu; Vincent Kam-Wai Wong; Hua Li; Mao Li; Xiao-Gang Zhou; Da-Lian Qin; An-Guo Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

7.  Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.

Authors:  Jun Ye; Xuejun Xia; Wujun Dong; Huazhen Hao; Luhua Meng; Yanfang Yang; Renyun Wang; Yuanfeng Lyu; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2016-08-24

8.  Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS.

Authors:  Saif Ahmad Khan; Saleha Rehman; Bushra Nabi; Ashif Iqubal; Nida Nehal; Usama A Fahmy; Sabna Kotta; Sanjula Baboota; Shadab Md; Javed Ali
Journal:  Pharmaceutics       Date:  2020-11-06       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.